Medtronic plc
MDTElectromedical & Electrotherapeutic Apparatus · SIC 3845 · CIK 0001613103
Revenue FY2026
$36.36B
Net Income
$4.80B
EPS (Basic)
$3.75
Net Margin
13.2%
ROE
9.7%
Total Equity
$49.46B
Shares Out
1.28B
Medtronic plc — Electromedical & Electrotherapeutic Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2026; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 17 funds in our universe
FundPosition Value% of AUMQoQ ChgWeight
Matrix Asset Advisors
David Katz
$0.03B
2.4%
+15.4%
Sound Shore Management
Harry Burn
$0.07B
1.9%
+1.6%
Olstein Capital Management
Robert Olstein
$0.01B
1.1%
—
WCM Investment Management
WCM Investment Management
$0.88B
0.9%
(3.9%)
First Eagle Investment Management
First Eagle
$1.08B
0.8%
+37.2%
Pzena Investment Management
Richard Pzena
$0.25B
0.3%
(0.3%)
Renaissance Technologies
Renaissance Technologies
$0.25B
0.3%
NEW
Mairs & Power
Mairs & Power
$0.03B
0.2%
(9.6%)
Hillman Capital Management
Hillman
$0.00B
0.2%
+55.6%
Capital Research Global Investors
Capital Research Global Investors
$1.04B
0.1%
(68.4%)
Dodge & Cox
Dodge & Cox
$0.62B
0.1%
+2.4%
Capital World Investors
Capital World Investors
$0.66B
0.1%
(49.3%)
Lansdowne Partners (UK)
Lansdowne Partners (UK)
$0.01B
0.1%
—
Adage Capital Management
Adage Capital Management
$0.04B
0.1%
(46.4%)
Veritas Asset Management
Veritas Asset Management
$0.01B
0.0%
(40.6%)
Bridgewater Associates
Bridgewater Associates
$0.04B
0.0%
+89.0%
Alps Advisors
Alps Advisors
$0.00B
0.0%
+79.1%
Insider Transactions
Reading stored insider transactions…